Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
43
Views
1
CrossRef citations to date
0
Altmetric
Case Studies

Milia within resolving bullous pemphigoid lesions

, BS, , MD & , MD, FAAD
Pages 90-92 | Received 21 Aug 2018, Accepted 24 Sep 2018, Published online: 14 Jan 2019

  • Bernard P, Antonicelli F. Bullous pemphigoid: a review of its diagnosis, associations and treatment. Am J Clin Dermatol. 2017;18(4):513–528. doi: 10.1007/s40257-017-0264-2.
  • Ahmed A, Shetty S, Kaveri S, Spigelman Z. Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: a retrospective study with a 6-year follow-up. J Am Acad Dermatol. 2016;74(4):700–708. doi: 10.1016/j.jaad.2015.11.030.
  • Amagai M, Ikeda S, Hashimoto T, et al. A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid. J Dermatol Sci. 2016; 85(2):77–84. doi: 10.1016/j.jdermsci.2016.11.003.
  • Lamberts A, Euverman H, Terra J, Jonkman MF, Horváth B. Effectiveness and safety of rituximab in recalcitrant pemphigoid diseases. J Invest Dermatol. 2018;138(5 Suppl):S71. doi: 10.1016/j.jid.2018.03.423.
  • Uchida S, Oiso N, Koga H, Ishii N, Okahashi K, Matsuda H, Hashimoto T, Kawada A. Refractory bullous pemphigoid leaving numerous milia during recovery. J Dermatol. 2014;41(11):1003–1005. doi: 10.1111/1346-8138.12650.
  • Prost C, Labeille B, Chaussade V, Guillaume JC, Martin N, Dubertret L. Immunoelectron microscopy in subepidermal autoimmune bullous diseases: a prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol. 1987;89(6):567–573. doi: 10.1111/1523-1747.ep12461226.
  • Tsuruta D, Brzezinski P, Koga H, Ohata C, Furumura M, Hashimoto T. Bullous pemphigoid with prominent milium formation. Acta Dermatovenerol Croat. 2013; 21(1):35–38.
  • Venning VA, Whitehead PH, Leigh IM, Allen J, Wojnarowska F. The clinical expression of bullous pemphigoid is not determined by the specificity of the target antigen. Br J Dermatol. 1991;125(6):561–565.
  • Banfield CC, Wojnarowska F, Allen J, George S, Venning VA, Welsh KI. The association of HLA-DQ7 with bullous pemphigoid is restricted to men. Br J Dermatol. 1998;138(6):1085–1090.
  • Hisa T, Goto Y, Taniguchi S, Nakanishi T, Kakudo K, Takigawa M. Post-bullous milia. Australas J Dermatol. 1996;37(3):153–154.
  • Ding S, Deng Q, Xiang Y, Chen J, Huang J, Lu J. Bullous pemphigoid associated with milia, increased serum IgE autoantibodies against desmogleins, and refractory treatment in a young patient. An Bras Dermatol. 2017;92(5):34–36. doi: 10.1590/abd1806-4841.20176124.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.